Russell Investments Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-83,461
| Closed | -$3.28M | – | 3687 |
|
|
2023
Q2 | $3.28M | Sell |
83,461
-5,948
| -7% | -$210K | 0.01% | 1280 |
|
|
2023
Q1 | $2.18M | Buy |
89,409
+8,609
| +11% | +$188K | ﹤0.01% | 1529 |
|
|
2022
Q4 | $1.73M | Hold |
80,800
| – | – | ﹤0.01% | 1685 |
|
|
2022
Q3 | $1.45M | Hold |
80,800
| – | – | ﹤0.01% | 1737 |
|
|
2022
Q2 | $777K | Hold |
80,800
| – | – | ﹤0.01% | 2072 |
|
|
2022
Q1 | $1.36M | Sell |
80,800
-2,442
| -3% | -$36.1K | ﹤0.01% | 1819 |
|
|
2021
Q4 | $1.39M | Sell |
83,242
-992
| -1% | -$16.3K | ﹤0.01% | 1994 |
|
|
2021
Q3 | $1.37M | Buy |
84,234
+3,434
| +4% | +$37.4K | ﹤0.01% | 2047 |
|
|
2021
Q2 | $509K | Hold |
80,800
| – | – | ﹤0.01% | 2590 |
|
|
2021
Q1 | $499K | Buy |
+80,800
| New | +$490K | ﹤0.01% | 2526 |
|
|
2020
Q3 | – | Sell |
-8,936
| Closed | -$47K | – | 3281 |
|
|
2020
Q2 | $47K | Buy |
8,936
+1,582
| +22% | +$6.59K | ﹤0.01% | 2991 |
|
|
2020
Q1 | $25K | Buy |
+7,354
| New | +$43K | ﹤0.01% | 2933 |
|
|
2019
Q3 | – | Sell |
-28,150
| Closed | -$37K | – | 3115 |
|
|
2019
Q2 | $37K | Buy |
28,150
+1,400
| +5% | +$1.92K | ﹤0.01% | 2764 |
|
|
2019
Q1 | $38K | Buy |
26,750
+2,100
| +9% | +$2.94K | ﹤0.01% | 2830 |
|
|
2018
Q4 | $30K | Sell |
24,650
-14,390
| -37% | -$27.9K | ﹤0.01% | 2841 |
|
|
2018
Q3 | $92K | Buy |
39,040
+1,540
| +4% | +$3.84K | ﹤0.01% | 2765 |
|
|
2018
Q2 | $102K | Sell |
37,500
-41,742
| -53% | -$115K | ﹤0.01% | 2737 |
|
|
2018
Q1 | $217K | Sell |
79,242
-50,425
| -39% | -$146K | ﹤0.01% | 2644 |
|
|
2017
Q4 | $402K | Buy |
+129,667
| New | +$365K | ﹤0.01% | 2501 |
|
|
2017
Q2 | – | Sell |
-15,921
| Closed | -$58K | – | 3065 |
|
|
2017
Q1 | $58K | Sell |
15,921
-2,523
| -14% | -$10.7K | ﹤0.01% | 2884 |
|
|
2016
Q4 | $91K | Buy |
+18,444
| New | +$547K | ﹤0.01% | 2897 |
|
Russell Investments Group's ISEE Position: Q3 2023 in Review
Russell Investments Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 83,461 shares — an estimated $3.28M sold.
Russell Investments Group first reported a position in ISEE in Q4 2016 and held it in 21 quarters. The position peaked at $3.28M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Russell Investments Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Russell Investments Group sold 83,461 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.28M.
- Russell Investments Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 21 quarters.
- Russell Investments Group's IVERIC bio, Inc. Common Stock position peaked at $3.28M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.